Press Releases

Biocon Biologics  /  Press Releases

Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%

  • Posted by: Biocon Biologics

EdelGive and Hurun India recognizes Kiran Mazumdar-Shaw as the Second most generous women philanthropist in India

  • Posted by: Biocon Biologics

Biocon Biologics Announces Divestment of Two Non-Core Branded Formulations – India Business Units

  • Posted by: Biocon Biologics

Biocon Ranked No. 8 Among Science Magazine’s Best Employers in Global Biotech and Pharma Sector

  • Posted by: Biocon Biologics

Kedar Upadhye Appointed as New CFO of Biocon Biologics Current CFO MB Chinappa to take on a Strategic Finance role at Biocon Group

  • Posted by: Biocon Biologics

Biocon Board Appoints Peter Bains as Group CEO

  • Posted by: Biocon Biologics

Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars’ Business In North America, Ahead of Schedule

  • Posted by: Biocon Biologics

Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%

  • Posted by: Biocon Biologics

Biocon Biologics Announces Key Leadership Appointments

  • Posted by: Biocon Biologics

Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept

  • Posted by: Biocon Biologics
Share
buy twitter followers